We take a look at some of the exciting diabetes research developments announced in October 2025, and what the findings could mean for people living with or affected by diabetes.

There are some very early clues to suggest that coronavirus might be triggering type 1 or type 2 diabetes in some people, or making the condition worse for others. We take a look at the evidence and ...

Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.

Scientists in the United States have announced early results from a pioneering trial testing a new stem cell treatment designed to replace insulin-producing beta cells in people with type 1 diabetes.

Everything you need to know about type 2 diabetes remission. Find out what type 2 diabetes remission is, how it works, and what the benefits are.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...

We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.

Our new analysis predicts that, without significant government action, up to 5.5m people in the UK could be living with diabetes by 2030.

UPDATE, 22 MAY 2024: We now have new information on the amount of people living with the diabetes, and for more information you can visit our guide on diabetes statistics. The number of people living ...

We’ve joined forces with the National Institute for Health Research (NIHR) to fund a new £2.2 million project, called NewDAWN, led by Professors Susan Jebb and Paul Aveyard at the University of Oxford ...